Related Experiment Video
Updated: Jun 13, 2026
07:03
In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Hemostatic alterations in fatty liver disease.
Ayse Kargili1, Handan Cipil, Feridun Karakurt
1Department of Internal Medicine, Fatih University Hospital, Ankara, Turkey.
Summary
Nonalcoholic fatty liver disease (NAFLD) patients show elevated plasminogen activator inhibitor 1. Clinicians should monitor hemostatic changes in fatty liver disease patients.
Area of Science:
- Hepatology
- Hematology
- Internal Medicine
Background:
- Nonalcoholic fatty liver disease (NAFLD) is a prevalent condition and a significant contributor to liver failure.
- Liver failure, regardless of its origin, is associated with disruptions in the body's hemostatic system.
- Understanding these hemostatic alterations is crucial for managing patients with liver disease.
Purpose of the Study:
- To investigate specific hemostasis parameters in patients diagnosed with NAFLD.
- To compare coagulation and fibrinolysis markers between NAFLD patients and healthy controls.
Main Methods:
- The study included 28 patients with ultrasound-proven NAFLD and 33 healthy volunteers.
- Evaluated parameters included protein C, protein S, factor 7, factor 8, platelet counts, prothrombin time (PT), activated partial thromboplastin time (aPTT), and plasminogen activator inhibitor 1 (PAI-1).
Main Results:
- Prothrombin time and activated partial thromboplastin time remained within normal ranges for both groups.
- NAFLD patients exhibited decreased levels of factor 7, factor 8, protein S, and protein C, though not statistically significant.
- Plasminogen activator inhibitor 1 levels were significantly elevated in NAFLD patients compared to controls.
Conclusions:
- Alterations in hemostatic parameters are expected in various forms of liver disease, including NAFLD.
- The significant increase in PAI-1 in NAFLD patients warrants clinical attention.
- Healthcare providers should be vigilant regarding hemostatic changes in patients with fatty liver disease due to its high prevalence.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:30Liver Physiology
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...